Streetbeat News

Stock Prices

ORAN

Orange Inc. (NYSE:ORAN) shares are trading at $11.71, marking a 0.43% increase in the current session, with a 1.87% increase over the past month but a 1.80% decrease over the past year. The company's P/E ratio of 12.66, compared to the industry average of 55.59, suggests it might be undervalued or expected to perform worse than its industry peers. Investors are advised to consider the P/E ratio among other financial metrics and qualitative factors for a comprehensive analysis.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 6:45 pm

NVO

SRRK

Raymond James initiated coverage on Scholar Rock Holding (NASDAQ:SRRK) with a Strong Buy rating and a $30 price target, highlighting its potential in the obesity and Spinal Muscular Atrophy (SMA) markets. The company's lead program, apitegromab, is in a Phase 3 trial for SMA, with results expected in Q4 2024. Scholar Rock is also exploring the obesity market with SRK-439, showing positive preclinical data. The company ended 2023 with $280 million in cash, expected to fund operations into 2H 2025. SRRK shares rose 15.50% to $17.19.

Portfolio Pulse from Vandana Singh

March 28, 2024 | 6:42 pm

OAIB

Patricia Mohr, an economist and commodities expert, predicts a resurgence in demand for copper and uranium due to the global shift toward greener energy. The Teucrium AiLA Long-Short Base Metals Strategy ETF (OAIB) is highlighted as an investment option in the base metals sector, with a focus on commodities like copper. Technical analysis suggests copper prices may rise in the medium-to-long term, despite currently trading in a descending channel pattern.

Portfolio Pulse from Melanie Schaffer

March 28, 2024 | 6:42 pm

BSX

Over the past 15 years, Boston Scientific (NYSE:BSX) has delivered an average annual return of 15.03%, turning a $1000 investment into $8,067.65 today. With a current market capitalization of $100.86 billion, BSX has outperformed the market by 2.08% on an annualized basis.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 6:30 pm

CAH

Over the past 5 years, Cardinal Health (NYSE:CAH) has outperformed the market with an annualized return of 18.85%, turning a $1000 investment into $2,276.67. The company's market capitalization stands at $27.26 billion.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 6:30 pm

CDNS

Cadence Design Sys Inc. (NASDAQ:CDNS) stock is currently priced at $311.12, reflecting a slight decrease of 0.07% in the current market session. Despite this, the stock has seen a 2.21% increase over the past month and a significant 48.08% increase over the past year. The company's P/E ratio is lower than the Software industry's aggregate P/E of 113.9, suggesting that it might be undervalued or that shareholders have conservative future growth expectations. Investors are advised to consider the P/E ratio alongside other financial metrics and qualitative analysis for a comprehensive investment decision.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 6:30 pm

AMGN

Raymond James has resumed coverage of Amgen Inc (NASDAQ:AMGN), highlighting its diversified portfolio across various therapeutic areas, which is expected to drive long-term growth. Recent deals, like the Horizon deal, and successful product launches have strengthened its position, particularly in rare diseases. However, concerns about the durability of flagship products and market challenges persist. The company's innovative pipeline in oncology, rare diseases, and obesity shows promise despite uncertainties. The FDA's review of Lumakras and the requirement for an additional study by 2028 are noted. Despite challenges, Amgen's confidence in sustaining margins remains, with the stock's risk-reward balance appearing stable.

Portfolio Pulse from Vandana Singh

March 28, 2024 | 6:28 pm

ATAT

Atour Lifestyle Holdings' shares are trading lower following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 6:27 pm

MRK

Recent unusual options activity in Merck & Co (NYSE:MRK) indicates a bullish sentiment among deep-pocketed investors, with a notable division in sentiment (54% bullish, 45% bearish). The activity includes 11 extraordinary options activities, with 9 puts and 2 calls, aiming for a price range of $100.0 to $130.0. Current trading volume is 4,072,408 with the price at $131.75. Analyst opinions vary, with an average target price of $130.2 and ratings ranging from Sell to Overweight.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 6:16 pm

VLO

Valero Energy (NYSE:VLO) has seen a mix of bullish and bearish options trading, with a notable lean towards bullish sentiment. Analysis of 12 unusual trades shows an even split in trader sentiment, but with a higher value placed on calls ($1,282,241) compared to puts ($64,225). The options market predicts a price range of $125 to $230 for VLO. The stock is currently up 1.35% at $170.08, with some analysts suggesting it may be overbought. Professional analysts have set an average price target of $184.4, with ratings ranging from Sell to Buy.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 6:16 pm